COMPARATIVE RESULTS OF LIVER TRANSPLANTATION IN PATIENTS WITH VIRAL CIRRHOSIS AND AUTOIMMUNE LIVER DISEASES AT A SINGLE CENTER
https://doi.org/10.15825/1995-1191-2012-1-36-40
Abstract
Russian Scientist Centre for Radiology and Surgical Technology has sufficient experience of orthotopic liver transplantation (100 OLT), which allowed comparing the outcomes of the terminal stages of liver disease in the two most numerous groups of patients: viral cirrhosis (VH) and autoimmune liver diseases (AILD). Despite the fact that patients with VH indicator of urgency performing OLT (MELD) lower, rate of deaths on the waiting list higher than AILD, due to more favorable course of immune disease. After OLT significant differences during the early and last posttransplant periods were not found, although the recurrences of viral hepatitis are recorded much more frequently than AILD. One-year and a three-year survival rates were comparable. To prevent reinfection of the hepatitis B successfully used nucleoside analogues (telbivudine), which allowed minimizing recurrence of the disease. Prevention and treatment of hepatitis C after the OLT is a relevant problem, despite the low efficiency of antiviral therapy. Relapses AILD not represent a real threat to the life of the patients, because the modification of immunosuppressive therapy can limit the progression of the disease.
About the Authors
O.A GerasimovaRussian Federation
D.A. Granov
Russian Federation
F.K. Zherebtsov
Russian Federation
References
1. Андрейцева О.И. Возможности ортотопической трансплантации печени при лечении больных с терминальными поражениями печени // Consilium medicum. 2004. No 6. C. 414–421.
2. Герасимова О.А., Гранов Д.А., Жеребцов Ф.К., Боровик В.В. Первый опыт применения телбивудина у больных после трансплантации печени // Вестник трансплантологии и искусcтвенных органов. 2010. Т. XII. No 1. С. 33–38.
3. Готье С.В., Мойсюк Я.Г., Ибрагимова О.С. Органное донорство и трансплантация в Российской Федерации в 2009 г. II сообщение регистра Российского трансплантологического общества // Вестник трансплантологии и искусственных органов. 2010. Т. XII. No 3. С. 6–15.
4. Бабенко Н.Н., Богорад И.В. и др. Клиническая трансплантология / Под ред. Б.А. Константинова. М., 2004. 304 с.
5.
6. 5. Тюняев А.А. К вопросу о корреляционной связи между этносом и группами крови // Organizmica. 2008. No 3 (15). C. 214–216.
7. Al Sibae M.R., Cappell M.S. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS // Dig. Dis. Sci. 2011. Vol. 56 (4). P. 977–987.
8. Balan V., Abu-Elmagd K., Demetris A.J. Autoimmune liver diseases. Recurrence after liver transplantation // Surg. Clin. North. Am. 1999. Vol. 79. P. 147–152.
9. Brown R.S., Lake J.R. The survival impact of liver transplantation the MELD era, and the future for organ allocation and distribution // Am. J. Transplant. 2005. Vol. 5. P. 203–205.
10. Olthoff K.M., Brown R.S., Delmonico F.L. et al. Summary report of a national conference: Evolving concepts in
11. liver transplantation in the MELD and PELD era // Liver Transpl. 2004. Vol. 10. Р. A6–A22.
12. Freeman R., Edwards E. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy // Liver Transpl. 2000. Vol. 6 P. 543–552.
13. Kamath P.S., Wiesner R.H., Malinchoc M. et al. A model to predict survival in patients with end- stage liver diseases // Hepatology. 2001. No 33. Vol. 2. P. 464–470.
14. Gordon F.D., Kwo P., Vargas H. Treatment of hepatitis C in liver transplant recipients // Liver Transplant. 2009. Vol. 15. P. 126–135.
15. Neuberger J., Gunson B., Hubscher S., Nightingale P. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation // Liver Transpl. 2004. Vol. 10. P. 488–491.
Review
For citations:
Gerasimova O., Granov D., Zherebtsov F. COMPARATIVE RESULTS OF LIVER TRANSPLANTATION IN PATIENTS WITH VIRAL CIRRHOSIS AND AUTOIMMUNE LIVER DISEASES AT A SINGLE CENTER. Russian Journal of Transplantology and Artificial Organs. 2012;14(1):36-40. https://doi.org/10.15825/1995-1191-2012-1-36-40
Email this article 